Tim Schmid

Executive Vice President, Worldwide Chairman, MedTech Johnson & Johnson

Last Reviewed: October 3, 2026

Executive Summary

Tim Schmid has run Johnson & Johnson’s medical devices business as Executive Vice President and Worldwide Chairman, MedTech since 2023. J&J puts MedTech at more than $30 billion in revenue and 75,000 employees, with thirteen billion-dollar platforms in orthopaedics, surgery, cardiovascular and vision that reach more than 300 million patients a year. A J&J employee since 1993, he has lived and worked in six countries, led the surgical business Ethicon as president and, from 2018 to 2023, ran MedTech in Asia Pacific. His career has been international throughout, and he took the top job after five years running J&J’s medical devices business in Asia.

Career Highlights

• Executive Vice President, Worldwide Chairman, MedTech at Johnson & Johnson since 2023.
• Company Group Chairman, MedTech Asia Pacific, 2018 to 2023.
• President of Ethicon, J&J’s surgical business.
• Chief Strategic Customer Officer of J&J MedTech.

Professional Journey

Schmid earned an undergraduate degree at the University of Western Ontario in Canada and an MBA at Richmond University in the United Kingdom, with further study in South Africa, Canada and the United Kingdom, according to his J&J biography.

He joined Johnson & Johnson in 1993 and has spent more than 30 years in leadership roles in its medical devices business across several continents, living and working in six countries. Among them he was chief strategic customer officer and president of Ethicon, the company’s surgical business.

From 2018 to 2023 he was company group chairman of J&J MedTech Asia Pacific. In 2023 he became executive vice president and worldwide chairman of MedTech and joined the executive committee. J&J describes the business he leads as a $30 billion-plus organization of more than 75,000 employees, with thirteen platforms of more than $1 billion each across orthopaedics, surgery, cardiovascular and vision.

He helped establish J&J’s global partnership with Operation Smile, the charity that provides surgical care to children with cleft lip or cleft palate. J&J operates two businesses, Innovative Medicine and MedTech, and its Innovative Medicine business alone exceeds $60 billion in annual revenue, according to the company. He sits on the executive committee alongside chief executive Joaquin Duato and the head of Innovative Medicine, Tom Cavanaugh.

The 2026 proxy lists a special committee of the board for the separation of J&J’s orthopaedics business, one of the platforms in the MedTech segment he leads; the filings read give no further detail. J&J’s biography credits him with leading business transformations and driving innovation.

Education

University of Western Ontario

Bachelor’s degree

Richmond University

MBA